MSN Laboratories Private Limited Exemestane Export Data — India (DGFT 2022–2026)

Name: MSN Laboratories Private Limited Exemestane Export Records India — #4 Exporter, 34 Shipments, $1.7M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Exemestane

India Pharmaceutical Trade Intelligence

$14.5M87 Suppliers57 CountriesHS 30049049

ExportsIndia → UNITED STATES39.3%India → BRAZIL12.2%

ImportsUNITED STATES → India$163.0K ITALY → India$146.4K

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: CARDINAL HEALTH

MSN Laboratories Private Limited — Exemestane Exporter #4 | $1.7M Trade Value | TransData Nexus | TransData Nexus

MSN Laboratories Private Limited — Exemestane Exporter Profile

Indian Pharmaceutical Exporter · #4 for Exemestane · $1.7M export value · DGFT Verified

MSN Laboratories Private Limited is the #4 Indian exporter of Exemestane with $1.7M in export value and 34 verified shipments. MSN Laboratories Private Limited holds a 11.7% market share in Exemestane exports across 1 countries. The company exports 32 pharmaceutical products worth $252.1M across 15 therapeutic categories.

MSN Laboratories Private Limited — Exemestane Export Profile: Buyers & Destinations

MSN Laboratories Private Limited Exemestane export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Exemestane?

Country	Value	Shipments	Share
UNITED STATES	$4.2M	83	37.3%
NETHERLANDS	$1.7M	80	15.2%
UNITED KINGDOM	$1.4M	27	12.1%
GERMANY	$882.2K	25

Who Are the Top Buyers of Exemestane from India?

Buyer	Country	Value	Orders
CARDINAL HEALTH	UNITED STATES	$800.0K	16
BROCACEF NL HUB	NETHERLANDS	$699.9K	20
FIEGE HEALTHCARE LOGISTICS GMBH	GERMANY	$604.5K	19
AUROBINDO PHARMA USA., INC,	UNITED STATES	$450.0K	9
CIPLA USA INC UPS SUPPLY CHAIN SOLU	UNITED STATES	$450.0K	9
XXDUSXXHARXXCEUXXCALXXUSAXXNC	UNITED STATES	$300.0K	6
ZYDUS PHARMACEUTICALS USA INC	UNITED STATES	$250.0K	5
M P L	UNITED KINGDOM	$200.0K	4
AUROBINDO PHARMA USA INC	UNITED STATES	$150.0K	3
AUROBINDO PHARMA USA., INC	UNITED STATES	$150.0K	3

India's Exemestane is purchased by 196 buyers worldwide. The top buyer is CARDINAL HEALTH (UNITED STATES), followed by BROCACEF NL HUB and FIEGE HEALTHCARE LOGISTICS GMBH.

How Does MSN Laboratories Private Limited Compare to Nearest Exemestane Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	INTAS PHARMACEUTICALS LIMITED	$4.5M	260	21	$17.3K
4	MSN LABORATORIES PRIVATE LIMITED ★	$1.7M	34	1	$50.0K
2	EUGIA PHARMA SPECIALITIES LIMITED	$1.4M	27	1	$50.0K
3	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$900.0K	18	4	$50.0K

MSN Laboratories Private Limited ranks #4 among 87 Indian Exemestane exporters. Average shipment value of $50.0K compared to the market average of $124.9K. The closest competitors by value are INTAS PHARMACEUTICALS LIMITED and EUGIA PHARMA SPECIALITIES LIMITED.

Which Indian Ports Ship Exemestane Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	314	20.5%
DELHI AIR CARGO ACC (INDEL4)	273	17.8%
SAHAR AIR	256	16.7%
DELHI AIR	128	8.3%
Bombay Air Cargo	62	4.0%
MUNDRA SEA (INMUN1)	52	3.4%
MUNDRA SEA	51	3.3%
AHEMDABAD AIR ACC (INAMD4)	50	3.3%

Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Exemestane Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like MSN Laboratories. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major shipping lines to alter routes. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, impacting the timely delivery of pharmaceutical products. (livemint.com)

Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, potentially benefiting Indian exporters. However, the imposition of tariffs on Indian pharmaceutical products poses a risk to export volumes, as higher tariffs can lead to increased costs and reduced competitiveness in the US market. (orfonline.org)

In the European Union, compliance with the Falsified Medicines Directive (FMD) requires stringent serialization and traceability measures. For companies like MSN Laboratories, adhering to these regulations is crucial to maintain market access and ensure the integrity of their supply chain.

MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practice (EU GMP) guidelines set rigorous quality benchmarks. Any lapses can lead to import bans, product recalls, and reputational damage.

MSN Laboratories' recent legal challenges, such as the patent litigation with Exelixis, Inc., highlight the importance of robust regulatory and intellectual property strategies. Ensuring compliance with evolving quality requirements and proactively addressing regulatory challenges are essential for sustaining export growth and market credibility.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Exemestane shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: MSN Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 57+ countries, 196+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Exemestane

Exemestane

MSN Laboratories Private Limited — Exemestane Exporter Profile

MSN Laboratories Private Limited — Exemestane Export Profile: Buyers & Destinations

Where Does India Export Exemestane?

Who Are the Top Buyers of Exemestane from India?

What Is India's Total Exemestane Export Value and How Much Does MSN Laboratories Private Limited Contribute?

What Is the Average Shipment Value for MSN Laboratories Private Limited's Exemestane Exports?

How Does MSN Laboratories Private Limited Compare to Other Indian Exemestane Exporters?

Regulatory Requirements: Exporting Exemestane to Key Markets

United States — FDA

United Kingdom — MHRA

How Does MSN Laboratories Private Limited Compare to Nearest Exemestane Exporters?

Which Indian Ports Ship Exemestane Exports?

What Other Advanced Oncology Products Does MSN Laboratories Private Limited Export?

Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Exemestane Exports

MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards

About MSN Laboratories Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Exemestane Export Data from MSN Laboratories Private Limited

Exemestane Stats

Company Overview

Top Products by MSN Laboratories Private Limited

Related Analysis

Need Detailed Export Data?

Data Source